Evidence map›Paper›PMID 19026398›Full record

ArticleAmerican journal of human genetics2008

Mutations in contactin-1, a neural adhesion and neuromuscular junction protein, cause a familial form of lethal congenital myopathy.

Alison G Compton, Douglas E Albrecht, Jane T Seto, Sandra T Cooper, Biljana Ilkovski, Kristi J Jones, Daniel Challis, David Mowat, Barbara Ranscht, Melanie Bahlo and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models.Molecular therapy. Methods & clinical development · 2024
    Article
  9. Article
  10. Genetic Mapping of Behavioral Traits Using the Collaborative Cross Resource.International journal of molecular sciences · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Alison G ComptonInstitute for Neuromuscular Research, The Children's Hospital at Westmead, NSW, Australia.
Douglas E Albrecht
Jane T Seto
Sandra T Cooper
Biljana Ilkovski
Kristi J Jones
Daniel Challis
David Mowat
Barbara Ranscht
Melanie Bahlo
Stanley C Froehner
Kathryn N North
Children's Hospital at Westmead · AUUniversity of Sydney · AUUniversity of Washington · USInstitute for Medical Research · USRoyal Hospital for Women · AUSydney Children's Hospital · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

Signalling via Dystrobrevin in Muscular DystrophyP01NS046788 · NINDS · UNIVERSITY OF WASHINGTON · PI FROEHNER, STANLEY C · 2004 to 2013
$12.8M
MOLECULAR INTERACTIONS IN CEREBELLAR GRANULE NEURONR01NS038297 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RANSCHT, BARBARA · 1999 to 2009
$3.5M
NINDS NIH HHS NS038297NINDS NIH HHS P01 NS046788NINDS NIH HHS R01 NS038297
6 · The paper itself

Abstract

We have previously reported a group of patients with congenital onset weakness associated with a deficiency of members of the syntrophin-alpha-dystrobrevin subcomplex and have demonstrated that loss of syntrophin and dystrobrevin from the sarcolemma of skeletal muscle can also be associated with denervation. Here, we have further studied four individuals from a consanguineous Egyptian family with a lethal congenital myopathy inherited in an autosomal-recessive fashion and characterized by a secondary loss of beta2-syntrophin and alpha-dystrobrevin from the muscle sarcolemma, central nervous system involvement, and fetal akinesia. We performed homozygosity mapping and candidate gene analysis and identified a mutation that segregates with disease within CNTN1, the gene encoding for the neural immunoglobulin family adhesion molecule, contactin-1. Contactin-1 transcripts were markedly decreased on gene-expression arrays of muscle from affected family members compared to controls. We demonstrate that contactin-1 is expressed at the neuromuscular junction (NMJ) in mice and man in addition to the previously documented expression in the central and peripheral nervous system. In patients with secondary dystroglycanopathies, we show that contactin-1 is abnormally localized to the sarcolemma instead of exclusively at the NMJ. The cntn1 null mouse presents with ataxia, progressive muscle weakness, and postnatal lethality, similar to the affected members in this family. We propose that loss of contactin-1 from the NMJ impairs communication or adhesion between nerve and muscle resulting in the severe myopathic phenotype. This disorder is part of the continuum in the clinical spectrum of congenital myopathies and congenital myasthenic syndromes.

Indexed as

MutationAmino Acid SequenceAmino Acid SubstitutionBase SequenceCase-Control StudiesCell Adhesion Molecules, NeuronalChromosome BreakageChromosome MappingChromosomes, Human, Pair 12Cohort StudiesConsanguinityConserved SequenceContactin 1ContactinsDNA Mutational AnalysisDystrophin-Associated ProteinsCell Adhesion Molecules, NeuronalCNTN1 protein, humanCntn1 protein, mouseContactin 1ContactinsdystrobrevinDystrophin-Associated ProteinsGenetic Markerssyntrophin

Identifiers

PMID19026398
PMCPMC2668069
OpenAlexW2023375902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.